Filing metadata

Accession number
0001209191-19-035061
Form type
Form 4
Filer
Adamas Pharmaceuticals Inc
CIK
CIK 1328143
Filed
Jun 06, 2019
Reporting period
Jun 05, 2019
Description
Insider transaction

Explore SEC Filings Hub